Figure 4. Meta-analysis of impact of PKM2 expression on disease-free survival/progression-free survival/recurrence-free survival of patients with solid cancers.
Results are presented as individual and pooled HR, and 95% CI.
Results are presented as individual and pooled HR, and 95% CI.